On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company's class of securities. This level of ownership classifies them as major shareholders, as they possess both sole voting and dispositive power over the shares. The filing asserts that the acquisition of these shares is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction that has such a purpose or effect. The principal business address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, located in New York, NY.

On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company's class of securities. This level of ownership classifies them as major shareholders, as they possess both sole voting and dispositive power over the shares. The filing asserts that the acquisition of these shares is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction that has such a purpose or effect. The principal business address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, located in New York, NY.